Current progress in neoantigen-based dendritic cell vaccines for solid tumors
Immunotherapy, particularly immune checkpoint inhibitors (ICIs) programmed death-ligand 1/programmed death-1 (PD-L1/PD-1) and cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4), has heralded a new era of tumor treatment. Although ICIs have clinical benefits, their complex heterogeneity and diverse...
| Published in: | Cancer Biology & Medicine |
|---|---|
| Main Authors: | Yuting Li, Abudukadierjiang Abudureheman, Jianming Xu |
| Format: | Article |
| Language: | English |
| Published: |
China Anti-Cancer Association
2025-10-01
|
| Subjects: | |
| Online Access: | https://www.cancerbiomed.org/content/22/10/1143 |
Similar Items
Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer
by: Xin Zhang, et al.
Published: (2023-01-01)
by: Xin Zhang, et al.
Published: (2023-01-01)
The Efficacy of Neoantigen-Loaded Dendritic Cell Vaccine Immunotherapy in Non-Metastatic Gastric Cancer
by: Menelaos Papakonstantinou, et al.
Published: (2025-07-01)
by: Menelaos Papakonstantinou, et al.
Published: (2025-07-01)
What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
by: Alec J. Redwood, et al.
Published: (2022-12-01)
by: Alec J. Redwood, et al.
Published: (2022-12-01)
Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
by: Yanwei Shen, et al.
Published: (2022-08-01)
by: Yanwei Shen, et al.
Published: (2022-08-01)
The landscape of neoantigens and its clinical applications: From immunobiology to cancer vaccines
by: Chiranjib Chakraborty, et al.
Published: (2024-01-01)
by: Chiranjib Chakraborty, et al.
Published: (2024-01-01)
Tumor neoantigens and tumor immunotherapies
by: Wang Jiani, et al.
Published: (2024-04-01)
by: Wang Jiani, et al.
Published: (2024-04-01)
Neoantigen Cancer Vaccines: Generation, Optimization, and Therapeutic Targeting Strategies
by: Carson R. Reynolds, et al.
Published: (2022-01-01)
by: Carson R. Reynolds, et al.
Published: (2022-01-01)
Immunological analysis of hybrid neoantigen peptide encompassing class I/II neoepitope-pulsed dendritic cell vaccine
by: Shinji Morisaki, et al.
Published: (2023-10-01)
by: Shinji Morisaki, et al.
Published: (2023-10-01)
Dendritic cell-derived exosomes induce monocyte antigen-presentation and immune amplification in neoantigen vaccine therapy
by: Shinji Morisaki, et al.
Published: (2025-05-01)
by: Shinji Morisaki, et al.
Published: (2025-05-01)
Reversing the “cold” tumor microenvironment: the role of neoantigen vaccines in prostate cancer
by: Jiani Wang, et al.
Published: (2025-07-01)
by: Jiani Wang, et al.
Published: (2025-07-01)
Neoantigens: new hope for cancer therapy
by: Yitong Hu, et al.
Published: (2025-03-01)
by: Yitong Hu, et al.
Published: (2025-03-01)
Neoantigen Identification and Dendritic Cell-Based Vaccines for Lung Cancer Immunotherapy
by: Komal Kumari, et al.
Published: (2024-05-01)
by: Komal Kumari, et al.
Published: (2024-05-01)
Depletion of regulatory T cells enhances the T cell response induced by the neoantigen vaccine with weak immunogenicity
by: Ruichen Huang, et al.
Published: (2025-01-01)
by: Ruichen Huang, et al.
Published: (2025-01-01)
Revamping Hepatocellular Carcinoma Immunotherapy: The Advent of Microbial Neoantigen Vaccines
by: Junze Liang, et al.
Published: (2024-08-01)
by: Junze Liang, et al.
Published: (2024-08-01)
Neoantigen-reactive T cells exhibit effective anti-tumor activity against colorectal cancer
by: Yaojun Yu, et al.
Published: (2022-01-01)
by: Yaojun Yu, et al.
Published: (2022-01-01)
Generalization of neoantigen-based tumor vaccine by delivering peptide-MHC complex via oncolytic virus
by: Chenyi Wang, et al.
Published: (2025-04-01)
by: Chenyi Wang, et al.
Published: (2025-04-01)
Current Trends in Neoantigen-Based Cancer Vaccines
by: Szu-Ying Ho, et al.
Published: (2023-03-01)
by: Szu-Ying Ho, et al.
Published: (2023-03-01)
Therapeutic Vaccines Targeting Neoantigens to Induce T-Cell Immunity against Cancers
by: Shih-Cheng Pao, et al.
Published: (2022-04-01)
by: Shih-Cheng Pao, et al.
Published: (2022-04-01)
Advanced immunotherapies for glioblastoma: tumor neoantigen vaccines in combination with immunomodulators
by: Berta Segura-Collar, et al.
Published: (2023-05-01)
by: Berta Segura-Collar, et al.
Published: (2023-05-01)
Generation of Tumor-Specific Cytotoxic T Cells From Blood via In Vitro Expansion Using Autologous Dendritic Cells Pulsed With Neoantigen-Coupled Microbeads
by: Adela Kiessling, et al.
Published: (2022-03-01)
by: Adela Kiessling, et al.
Published: (2022-03-01)
Neoantigen cancer vaccines: a new star on the horizon
by: Xiaoling Li, et al.
Published: (2024-04-01)
by: Xiaoling Li, et al.
Published: (2024-04-01)
Recent advances in neoantigen vaccines for treating non‐small cell lung cancer
by: Shu Su, et al.
Published: (2023-12-01)
by: Shu Su, et al.
Published: (2023-12-01)
Neoantigen peptide-pulsed dendritic cell vaccine therapy after surgical treatment of pancreatic cancer: a retrospective study
by: Koki Oyama, et al.
Published: (2025-04-01)
by: Koki Oyama, et al.
Published: (2025-04-01)
Dendritic Cell Immunotherapy for Solid Tumors: Advances in Translational Research and Clinical Application
by: Mi Eun Kim, et al.
Published: (2025-10-01)
by: Mi Eun Kim, et al.
Published: (2025-10-01)
Development and Clinical Applications of Therapeutic Cancer Vaccines with Individualized and Shared Neoantigens
by: Qing Hao, et al.
Published: (2024-06-01)
by: Qing Hao, et al.
Published: (2024-06-01)
Nanomaterial Delivery Vehicles for the Development of Neoantigen Tumor Vaccines for Personalized Treatment
by: Xiaoyu Huang, et al.
Published: (2024-03-01)
by: Xiaoyu Huang, et al.
Published: (2024-03-01)
Cancer neoantigens and immunogenicity: mutation position matters
by: Aude-Hélène Capietto, et al.
Published: (2020-05-01)
by: Aude-Hélène Capietto, et al.
Published: (2020-05-01)
Progress and challenges of personalized neoantigens in the clinical treatment of tumors
by: Hongyu Zhang, et al.
Published: (2020-06-01)
by: Hongyu Zhang, et al.
Published: (2020-06-01)
Circular RNA‐based neoantigen vaccine for hepatocellular carcinoma immunotherapy
by: Fei Wang, et al.
Published: (2024-08-01)
by: Fei Wang, et al.
Published: (2024-08-01)
Antitumor mRNA vaccines based on neoantigens
by: E. V. Starostina, et al.
Published: (2025-01-01)
by: E. V. Starostina, et al.
Published: (2025-01-01)
A Neoantigen-Based Peptide Vaccine for Patients With Advanced Pancreatic Cancer Refractory to Standard Treatment
by: Zheling Chen, et al.
Published: (2021-08-01)
by: Zheling Chen, et al.
Published: (2021-08-01)
Comprehensive analysis of neoantigens derived from structural variation across whole genomes from 2528 tumors
by: Yang Shi, et al.
Published: (2023-07-01)
by: Yang Shi, et al.
Published: (2023-07-01)
Neoantigen vaccines: advancing personalized cancer immunotherapy
by: Alaa A. A. Aljabali, et al.
Published: (2025-04-01)
by: Alaa A. A. Aljabali, et al.
Published: (2025-04-01)
The Value of Microbes in Cancer Neoantigen Immunotherapy
by: Junrui Tian, et al.
Published: (2023-08-01)
by: Junrui Tian, et al.
Published: (2023-08-01)
Computational cancer neoantigen prediction: current status and recent advances
by: G. Fotakis, et al.
Published: (2021-12-01)
by: G. Fotakis, et al.
Published: (2021-12-01)
Identification of neoantigen epitopes in cervical cancer by multi-omics analysis
by: Jing Yuan, et al.
Published: (2025-08-01)
by: Jing Yuan, et al.
Published: (2025-08-01)
A poly-neoantigen DNA vaccine synergizes with PD-1 blockade to induce T cell-mediated tumor control
by: Elena Tondini, et al.
Published: (2019-11-01)
by: Elena Tondini, et al.
Published: (2019-11-01)
A therapeutic regimen using neoantigen-specific TCR-T cells for HLA-A*2402-positive solid tumors
by: Yuncheng Bei, et al.
Published: (2025-01-01)
by: Yuncheng Bei, et al.
Published: (2025-01-01)
Development of neoantigens: from identification in cancer cells to application in cancer vaccines
by: Nasim Ebrahimi, et al.
Published: (2022-07-01)
by: Nasim Ebrahimi, et al.
Published: (2022-07-01)
Neoantigens and their clinical applications in human gastrointestinal cancers
by: Zahra Shokati Eshkiki, et al.
Published: (2022-09-01)
by: Zahra Shokati Eshkiki, et al.
Published: (2022-09-01)
Similar Items
-
Research progress of neoantigen-based dendritic cell vaccines in pancreatic cancer
by: Xin Zhang, et al.
Published: (2023-01-01) -
The Efficacy of Neoantigen-Loaded Dendritic Cell Vaccine Immunotherapy in Non-Metastatic Gastric Cancer
by: Menelaos Papakonstantinou, et al.
Published: (2025-07-01) -
What’s next in cancer immunotherapy? - The promise and challenges of neoantigen vaccination
by: Alec J. Redwood, et al.
Published: (2022-12-01) -
Neoantigen vaccine and neoantigen‐specific cell adoptive transfer therapy in solid tumors: Challenges and future directions
by: Yanwei Shen, et al.
Published: (2022-08-01) -
The landscape of neoantigens and its clinical applications: From immunobiology to cancer vaccines
by: Chiranjib Chakraborty, et al.
Published: (2024-01-01)
